After attacking a tumor with a targeted therapy, the cancer might stagger but often comes back fighting—usually even harder to defeat. University of Saskatchewan (USask)-led research has revealed a promising strategy to ...
Mar 29, 2023
0
27
Clinical researchers from Oxford University's Department of Psychiatry and Oxford Health NHS Foundation Trust have reviewed the international research evidence regarding the impact of viewing images of self-harm on the internet ...
Mar 21, 2023
0
0
The biological function of the C-reactive protein, CRP, has long been unknown. Researchers at Linköping University in Sweden now show that this protein has a beneficial function in systemic lupus erythematosus, SLE, an inflammatory ...
Mar 9, 2023
0
26
Immunotherapy has been shown to greatly improve survival rates for certain types of cancer. However, in some cases, it can lead to an over-activation of the immune system, which can be dangerous. In a recent review by researchers ...
Mar 8, 2023
0
2
Spinal cord stimulation, a medical technology suggested to treat people with chronic back pain, does not provide long-term relief and may cause harm, according to a Cochrane Review released today.
Mar 8, 2023
0
76
Ozempic has been catapulted into the public eye in recent months as celebrities and wellness influencers started taking it for weight loss. But Ozempic is a diabetes drug—and the craze has led to a shortage, leaving those ...
Mar 1, 2023
0
12
Three years into the COVID-19 pandemic, new variant outbreaks continue to fuel economic disruptions and hospitalizations across the globe. Effective therapies remain unavailable in much of the world, and circulating variants ...
Feb 21, 2023
0
10
Digital systems for patients to monitor and report symptoms remotely may offer a solution to reduce outpatient waiting lists, according to a new review published by the Journal of the Royal Society of Medicine.
Feb 9, 2023
0
49
Radiotherapy (RT) is a primary method of tumor treatment. However, in clinical practice, radiotherapy still suffers from shortcomings such as serious side effects, limited efficacy, and tumor metastasis and recurrence due ...
Jan 10, 2023
0
2
Patient-reported outcomes from individuals diagnosed with relapsed or refractory large B-cell lymphoma revealed that those who received axicabtagene ciloleucel (axi-cel) immunotherapy experienced higher quality of life than ...
Jan 4, 2023
0
10
